Bluesky Facebook Reddit Email

Yearly mass antibiotic treatment could help eliminate leading cause of blindness

10.06.05 | The Lancet_DELETED

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Chlamydia trachomatis causes trachoma, an infection of the eyes that may result in blindness after repeated re-infection. Trachoma is the world's leading cause of blindness. Previous studies have suggested that eye infection with C. trachomatis could be eliminated after one mass treatment with antibiotics. However, Sheila West (The Johns Hopkins School University, Baltimore, MD, USA) and colleagues found that in an area of Tanzania with high levels of the bacterium, mass treatment significantly reduced the prevalence of infection in the community but infection re-emerged after 1-year.

Professor West states: "The findings of our community based study show that antibiotic coverage as high as 86% decreases, but does not eliminate, ocular infection with C trachomatis over 18 months. Trachoma and infectious load began to rise 12 months after treatment, suggesting that yearly mass treatment for this community would be effective."

Contact: Professor Sheila West, The Wilmer Eye Institute, Rm 129, The Johns Hopkins School University, 600 North Wolf Street, Baltimore MD 21287-9019, USA. T) +1 410 955 2606 shwest@jhmi.edu

The Lancet

Keywords

Article Information

Contact Information

How to Cite This Article

APA:
The Lancet_DELETED. (2005, October 6). Yearly mass antibiotic treatment could help eliminate leading cause of blindness. Brightsurf News. https://www.brightsurf.com/news/19VVRX58/yearly-mass-antibiotic-treatment-could-help-eliminate-leading-cause-of-blindness.html
MLA:
"Yearly mass antibiotic treatment could help eliminate leading cause of blindness." Brightsurf News, Oct. 6 2005, https://www.brightsurf.com/news/19VVRX58/yearly-mass-antibiotic-treatment-could-help-eliminate-leading-cause-of-blindness.html.